A decision aid for GPs for the treatment of elderly male patients with lower urinary tract symptoms (LUTS)

被引:3
作者
Norg, Roelf J. C.
Portegijs, Piet J. M.
van de Beek, Kees
van Schayck, Onno
Knottnerus, J. Andre
机构
[1] Univ Maastricht, Care & Publ Hlth Res Inst, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands
[2] Univ Hosp Maastricht, Dept Urol, Maastricht, Netherlands
关键词
benign prostatic hyperplasia; diagnosis; lower urinary tract symptoms; therapy;
D O I
10.1093/fampra/cml028
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. GPs have four main treatment options for lower urinary tract symptoms (LUTS): watchful waiting, alpha-blockers, 5-alpha-reductase inhibitors or (referral for) surgery. Guidelines do not provide clear cut-off values for (combinations of) symptoms and physical examination results to decide which treatment is best. Objective. (i) To develop a decision aid ('checklist') for GPs for the treatment of patients with LUTS. (ii) To assess its value for use in a primary care population. Materials and methods. Population-based cross-sectional study. Included were subjects with uncomplicated LUTS for whom treatment in primary care may be appropriate. [International Prostate Symptom Score (IPSS) >= 8, no prior prostate surgery, prostate-specific antigen (PSA) value < 10 ng/ml]. For each subject the appropriateness of surgery and alpha-blocker treatment was determined using a previously validated formalized international expert panel judgement. Regression models using data available in primary care were constructed to predict the panel judgement. Subsequently these models were transformed into simple checklists. Finally, the efficiency of these checklists was calculated. Results. The best checklists consisted of age, symptoms severity, type of symptoms, a quality of life score and PSA value. Assuming one would like to provide at least 95% of the subjects for whom a certain treatment is appropriate with this treatment (i.e. 'sensitivity' of the checklist >= 95%), one can reach a positive predictive value of 50-60%. Conclusion. Simple checklists based on the judgement of experts regarding the most appropriate therapy can help GPs to advise their patients of a rational treatment strategy.
引用
收藏
页码:666 / 673
页数:8
相关论文
共 6 条
  • [1] Management of symptomatic BPH in the US: Who is treated and how?
    Bruskewitz, R
    [J]. EUROPEAN UROLOGY, 1999, 36 : 7 - 13
  • [2] DELAROSETTE JJ, 2004, GUIDELINE BENIGN PRO
  • [3] The appropriateness of treatment of benign prostatic hyperplasia: a comparison of Dutch and multinational criteria
    McDonnell, J
    Stoevelaar, HJ
    Bosch, JLHR
    Kahan, JP
    [J]. HEALTH POLICY, 2001, 57 (01) : 45 - 56
  • [4] Guideline for the primary care management of male lower urinary tract symptoms
    Speakman, MJ
    Kirby, RS
    Joyce, A
    Abrams, P
    Pocock, R
    [J]. BJU INTERNATIONAL, 2004, 93 (07) : 985 - 990
  • [5] Treatment choice for benign prostatic hyperplasia: A matter of urologist preference?
    Stoevelaar, HJ
    Van de Beek, C
    Casparie, AF
    McDonnell, J
    Nijs, HGT
    [J]. JOURNAL OF UROLOGY, 1999, 161 (01) : 133 - 138
  • [6] Wolters RJ, 2004, HUISARTS WET, V47, P571